State and self investments in health
► State investments can crowd out or reinforce self investments in health. ► The UK NHS invested substantially in better care of cardiovascular disease (CVD). ► CVD patients receiving lipid-lowering drugs are more likely to quit smoking. ► Results robust to controlling for direct effect of smoking c...
Uloženo v:
| Vydáno v: | Journal of health economics Ročník 30; číslo 6; s. 1164 - 1173 |
|---|---|
| Hlavní autoři: | , |
| Médium: | Journal Article |
| Jazyk: | angličtina |
| Vydáno: |
Netherlands
Elsevier B.V
01.12.2011
Elsevier Elsevier Sequoia S.A |
| Témata: | |
| ISSN: | 0167-6296, 1879-1646, 1879-1646 |
| On-line přístup: | Získat plný text |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
| Shrnutí: | ► State investments can crowd out or reinforce self investments in health. ► The UK NHS invested substantially in better care of cardiovascular disease (CVD). ► CVD patients receiving lipid-lowering drugs are more likely to quit smoking. ► Results robust to controlling for direct effect of smoking cessation advice. ► Doctors compensate for patients’ attitude to health with medical treatment.
In this paper we consider how State investments can crowd out or reinforce self-investments in health using a theoretical model of insurance and protection. We apply this model to the smoking cessation decision made by individuals diagnosed with a cardiovascular disease using data from the 1998, 2003 and 2006 waves of the Health Survey of England. Prescription of lipid-lowering drugs, which increased substantially over this period, is used as the measure of State investment. Using bivariate and trivariate probit models, we allow for the endogeneity of the doctor's decision to prescribe and offer smoking cessation advice. We find that unobservable characteristics affecting the prescription of drugs are positively correlated with those affecting smoking advice and negatively correlated with those affecting the propensity to quit. Our results indicate that prescription of lipid-lowering drugs to individuals with cardiovascular disease increases the probability of smoking cessation by 20–28 percentage points. |
|---|---|
| Bibliografie: | SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 14 ObjectType-Article-1 ObjectType-Feature-2 content type line 23 ObjectType-Article-2 |
| ISSN: | 0167-6296 1879-1646 1879-1646 |
| DOI: | 10.1016/j.jhealeco.2011.09.002 |